236 related articles for article (PubMed ID: 14662844)
1. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.
Song X; Voronov E; Dvorkin T; Fima E; Cagnano E; Benharroch D; Shendler Y; Bjorkdahl O; Segal S; Dinarello CA; Apte RN
J Immunol; 2003 Dec; 171(12):6448-56. PubMed ID: 14662844
[TBL] [Abstract][Full Text] [Related]
2. IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity.
Eguchi J; Kuwashima N; Hatano M; Nishimura F; Dusak JE; Storkus WJ; Okada H
J Immunol; 2005 Jun; 174(11):7194-201. PubMed ID: 15905564
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
4. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
5. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
Apte RN; Dotan S; Elkabets M; White MR; Reich E; Carmi Y; Song X; Dvozkin T; Krelin Y; Voronov E
Cancer Metastasis Rev; 2006 Sep; 25(3):387-408. PubMed ID: 17043764
[TBL] [Abstract][Full Text] [Related]
6. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN
J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
Krelin Y; Voronov E; Dotan S; Elkabets M; Reich E; Fogel M; Huszar M; Iwakura Y; Segal S; Dinarello CA; Apte RN
Cancer Res; 2007 Feb; 67(3):1062-71. PubMed ID: 17283139
[TBL] [Abstract][Full Text] [Related]
8. Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.
Fujiwara H; Yamauchi N; Sato Y; Sasaki K; Takahashi M; Okamoto T; Sato T; Iyama S; Koshita Y; Hirayama M; Yamagishi H; Niitsu Y
Jpn J Cancer Res; 2000 Dec; 91(12):1296-302. PubMed ID: 11123429
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity.
Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Fima E; Hacham M; Huleihel M; Benharroch D
Immunol Lett; 1993 Dec; 39(1):45-52. PubMed ID: 8144190
[TBL] [Abstract][Full Text] [Related]
10. Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer.
Douvdevani A; Huleihel M; Zöller M; Segal S; Apte RN
Int J Cancer; 1992 Jul; 51(5):822-30. PubMed ID: 1612788
[TBL] [Abstract][Full Text] [Related]
11. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
13. CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.
Song X; Krelin Y; Dvorkin T; Bjorkdahl O; Segal S; Dinarello CA; Voronov E; Apte RN
J Immunol; 2005 Dec; 175(12):8200-8. PubMed ID: 16339559
[TBL] [Abstract][Full Text] [Related]
14. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
[TBL] [Abstract][Full Text] [Related]
15. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
16. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
[TBL] [Abstract][Full Text] [Related]
17. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
[TBL] [Abstract][Full Text] [Related]
18. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
Apte RN; Krelin Y; Song X; Dotan S; Recih E; Elkabets M; Carmi Y; Dvorkin T; White RM; Gayvoronsky L; Segal S; Voronov E
Eur J Cancer; 2006 Apr; 42(6):751-9. PubMed ID: 16530403
[TBL] [Abstract][Full Text] [Related]
19. IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas.
Apte RN; Douvdevani A; Huleihel M; Fima E; Hacham M; Shimoni N; Dvorkin T; Segal S
Folia Biol (Praha); 1992; 38(3-4):240-57. PubMed ID: 1426419
[TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.
Vanhaesebroeck B; Mareel M; Van Roy F; Grooten J; Fiers W
Cancer Res; 1991 Apr; 51(8):2229-38. PubMed ID: 2009541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
